In collaboration with CEEK Enterprises, HealthPrize recently released a new report, “The Pharmaceutical Triple Aim,” about how higher medication adherence improves patient outcomes and lowers health care costs.

Pharma companies can be part of adherence solutions, or at least pay for them. But here’s the thing: Pharma won’t do much of anything unless it’s shown to be able to increase revenue and boost earnings per share. This report shows how that can be done if adherence is improved.